Literature DB >> 19309690

Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.

Willemijn B Breunis1, Edwin van Mirre, Judy Geissler, Nadja Laddach, Gertjan Wolbink, Ellen van der Schoot, Masja de Haas, Martin de Boer, Dirk Roos, Taco W Kuijpers.   

Abstract

Human Fcgamma receptors (FcgammaRs) are glycoproteins that bind the Fc region of IgG. The genes encoding the low-affinity FcgammaRs are located on chromosome 1q23-24. Beside single nucleotide polymorphisms (SNPs), gene copy number variation (CNV) is now being recognized as an important indicator for inter-individual differences. Recent studies on identifying CNV in the human genome suggest large areas at chromosome 1q23-24 to be involved, and CNV in this region has been associated with manifestations of systemic autoimmune disease. To study both SNPs and CNV of the low-affinity FcgammaRs in one assay, we have developed a Multiplex Ligation-dependent Probe Amplification (MLPA) assay. A novel CNV for FCGR3A was observed. Similar to FCGR3B and FCGR2C, a gene-dosage effect of FCGR3A was found, that seemed to correlate nicely with the FcgammaRIIIa expression on NK cells. Next, we delineated the approximate boundaries of CNV at the FCGR locus. Variation in co-segregation of neighboring FCGR genes was limited to four variants, with patterns of Mendelian inheritance. No CNV of the FCGR2A and FCGR2B genes was observed in over 600 individuals. In conclusion, we report a novel CNV of the FCGR3A gene that correlates with FcgammaRIIIa expression and function on NK cells. Only FCGR3A, FCGR2C and FCGR3B show CNV, in contrast to FCGR2A and FCGR2B. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309690     DOI: 10.1002/humu.20997

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  74 in total

1.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

Authors:  Chiea Chuen Khor; Sonia Davila; Willemijn B Breunis; Yi-Ching Lee; Chisato Shimizu; Victoria J Wright; Rae S M Yeung; Dennis E K Tan; Kar Seng Sim; Jie Jin Wang; Tien Yin Wong; Junxiong Pang; Paul Mitchell; Rolando Cimaz; Nagib Dahdah; Yiu-Fai Cheung; Guo-Ying Huang; Wanling Yang; In-Sook Park; Jong-Keuk Lee; Jer-Yuarn Wu; Michael Levin; Jane C Burns; David Burgner; Taco W Kuijpers; Martin L Hibberd
Journal:  Nat Genet       Date:  2011-11-13       Impact factor: 38.330

2.  Intravenous immunoglobulins. Current understanding and future directions.

Authors:  S Jolles; S V Kaveri; J Orange
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 3.  Intravenous immunoglobulins--understanding properties and mechanisms.

Authors:  A Durandy; S V Kaveri; T W Kuijpers; M Basta; S Miescher; J V Ravetch; R Rieben
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

4.  FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.

Authors:  Julien Lejeune; Benoît Piègu; Valérie Gouilleux-Gruart; Marc Ohresser; Hervé Watier; Gilles Thibault
Journal:  MAbs       Date:  2012-10-02       Impact factor: 5.857

5.  Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.

Authors:  David L Morris; Amy L Roberts; Abigail S Witherden; Ruth Tarzi; Paula Barros; John C Whittaker; Terence H Cook; Timothy J Aitman; Timothy J Vyse
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

Review 6.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

7.  FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.

Authors:  Amy K Erbe; Wei Wang; Jacob Goldberg; Mikayla Gallenberger; KyungMann Kim; Lakeesha Carmichael; Dustin Hess; Eneida A Mendonca; Yiqiang Song; Jacquelyn A Hank; Su-Chun Cheng; Sabina Signoretti; Michael Atkins; Alexander Carlson; James W Mier; David J Panka; David F McDermott; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2016-10-14       Impact factor: 12.531

8.  Evolutionary history of copy-number-variable locus for the low-affinity Fcγ receptor: mutation rate, autoimmune disease, and the legacy of helminth infection.

Authors:  Lee R Machado; Robert J Hardwick; Jennifer Bowdrey; Helen Bogle; Timothy J Knowles; Manuela Sironi; Edward J Hollox
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

Review 9.  Bringing immunoglobulin knowledge up to date: how should we treat today?

Authors:  S Misbah; T Kuijpers; J van der Heijden; B Grimbacher; D Guzman; J Orange
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

10.  FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response.

Authors:  Robert Makowsky; Howard W Wiener; Travis S Ptacek; Miriam Silva; Aditi Shendre; Jeffrey C Edberg; Michael A Portman; Sadeep Shrestha
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.